Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and autoimmune diseases, will present updated clinical and ...

Trump misstated $8 million spent on transgender mice, sparking debate on transgenic research and its importance in science.

Precision Medicine Online's 2024 survey shows biomarker test expansion but low clinical trial enrollment and long wait times ...

A team at Baylor College of Medicine conducted research to identify novel cell-surface cancer/germline antigens (CGAs) expressed in triple-negative breast cancer (TNBC) that could serve as targets for ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

SESAUA annual meeting featured a kidney cancer session and a presentation by Dr. Robert Smith discussing how age and tumor ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

Among the many solar technologies being explored, perovskite solar cells have gained attention for their efficiency and low manufacturing costs. However, a major challenge stands in the way: they ...

When a gene gets duplicated, it often leads to the recipe being followed too many times, and the resulting “leftovers,” the excess proteins, are generally bad for the cell, Alvarez-Ponce said.

Genetic testing, via germline and somatic testing, is crucial in breast cancer to understand inherited risks and tumor behavior. Germline testing identifies hereditary mutations aiding in preventive ...

05). Of those tested, 50 (17%) harbored a germline pathogenic or likely pathogenic variant. In the AMAZONA III trial, 1,476 (49%) of 2,974 patients with BC met the National Comprehensive Cancer ...